ClinicalTrials.gg
RecruitingNCT07212673Updated Nov 4, 2025

Combining Digital Cognitive-behavior Therapy With Mindfulness Training for Binge Eating Disorder

An interventional study of CBT-based Mindful Courage and Coached Self-Monitoring in Binge Eating Disorder, sponsored by Yeshiva University. Recruiting at 1 site in United States. Open to participants aged 18 Years to 70 Years. Per ClinicalTrials.gov, last updated 2025-11-04.

Sponsored by Yeshiva University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Started Nov 2025; still recruiting 1 year later.
Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Randomized
Ages
18 Years to 70 Years
Sex
All
01

Study summary

The investigators will evaluate the acceptability and feasibility of a 16-session digital mindfulness-based and cognitive behavioral therapy (CBT) intervention for binge eating disorder (BED) + coached self-monitoring vs. a coached self-monitoring intervention. This study is a pilot randomized controlled trial.

Read the detailed description

Procedures include completing: (1) pre-intervention screening assessment; (2) an initial baseline visit; (3) the assigned intervention; (4) a mid-study visit; (5) a post-intervention assessment (\~18-weeks after baseline); and (6) a 2-month follow-up assessment.

02

Conditions studied

  • Binge Eating Disorder

Keywords

  • binge eating
  • eating disorder
  • obesity
03

In context

Binge-Eating Disorder

233 studies on the registry are indexed under Binge-Eating Disorder; 53 are open to participants now.

This study's planned enrollment of 40 is below the median of 77 across 190 interventional studies indexed under Binge-Eating Disorder.

Browse Binge-Eating Disorder studies →

Lead sponsor

Yeshiva University is the lead sponsor of 8 studies on the registry; 3 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 70 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • age 18 years or older
  • ability to speak English fluently
  • meeting criteria for current BED (i.e., in the past three months)
  • willing and able to commit to the entire study protocol

Exclusion criteria

Exclusion Criteria:

  • a below 18.5
  • requiring immediate treatment for medical complications
  • having current anorexia or bulimia nervosa or purging behaviors within the past year
  • being pregnant or breast-feeding
  • experiencing other severe psychopathology or medical illness that would limit the participants' ability to comply with the demands of the current study (e.g. active suicidal risk, active psychotic disorder, unmedicated bipolar disorder, severe substance use disorder, cancer)
  • currently receiving BED or weight loss treatment (treatment for other conditions will be allowed, as long as the treatment is not mindfulness-based)
  • currently taking medications for weight loss, or beginning medications that affect eating/weight within the last six months.
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

DSM diagnostic criteria

The American Psychiatric Association’s manual of mental health diagnoses. DSM-5 (2013, revised as DSM-5-TR in 2022) replaced DSM-IV, and some studies still name the older edition. “Meets DSM criteria for …” means diagnosed by that edition’s diagnostic criteria, usually by a clinician in an interview.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
40 participants (estimated)

Study arms

  • Experimental
    CBT-based Mindful Courage + Coached Self-Monitoring

    CBT-based Mindful Courage is a digital intervention including mindfulness and CBT elements for individuals with binge eating disorder. It will consist of 16 self-guided modules. Elements included in the intervention include psychoeducation, self-monitoring, regular eating, goal-setting, weekly weighing, eating a sufficient amount of food at each meal, eating a range of foods reduction of overvaluation of weight and shape, addressing shape/body checking or avoidance, behavior chain analysis, problem solving, awareness and acceptance of binge eating urges, thoughts and emotions, values awareness, values clarification, values-based decision making, self-compassion, exploring needs underlying binge eating urges, mindful eating, hunger and fullness awareness, self-compassion, and self-care. Weekly mindfulness practice (at least 3x per week) is heavily emphasized. Participants will also be asked to self-monitor their food intake in Recovery Record and will receive phone coaching.

    Behavioral: CBT-based Mindful Courage · Behavioral: Coached Self-Monitoring

  • Active comparator
    Coached Self-Monitoring

    Participants will be asked to self-monitor their food intake in Recovery Record and will receive phone coaching

    Behavioral: Coached Self-Monitoring

Interventions

  • BehavioralCBT-based Mindful Courage

    Self-guided online intervention

  • BehavioralCoached Self-Monitoring

    Participants will log meals in recovery record

06

What researchers measure

Primary outcomes

  1. Feasibility / Completion (questionnaire developed by our lab)

    Number of participants completing intervention

    Time frame: From baseline to 2-month follow-up visit

  2. Acceptability

    Dimensions of usability from the System Usability Scale; single-items measuring dimensions of acceptability, including overall satisfaction, engagement, visual appeal of content, understandability of program content, desire to continue the program, perceived skill acquisition, perceived confidence in implementing skills, and perceived helpfulness. Scores for each item range from 1 to 5, with higher scores indicating better acceptability. Scores will be averaged to obtain acceptability ratings.

    Time frame: After completing intervention, an average of 18-weeks

07

Study locations

1 of 1 sites recruiting
  • Yeshiva University
    The Bronx, New York 10461, United States
    Recruiting
08

References and documents

Publications

  • Sala M, Roos C, Ascarrunz D, Stern CM, Bricker J, Feldman JM, Levinson C, Aslan M, Hay JL, Kober H. Combining Digital Cognitive Behavioral Therapy With Mindfulness Training for Binge Eating Disorder: Protocol for a Feasibility Trial. JMIR Res Protoc. 2026 Apr 17;15:e91761. doi: 10.2196/91761. PubMed 42061840 ↗

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Nov 2025 (actual). Primary completion is estimated for Oct 2027, 22 months after the start.

Of 84 non-industry interventional studies with no phase under Binge-Eating Disorder, half reached primary completion within 34 months of starting (the median), counting those still running; a quarter within 16 and three quarters within 53. This study's planned 22 months is below that.

Counting every sponsor, half of 89 studies reached it within 25 months; a quarter within 16 and three quarters within 53.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 17, 2025
First posted
Oct 8, 2025
StartActual
Nov 2, 2025
Primary completionEst.
Oct 1, 2027
CompletionEst.
Oct 1, 2027
Last update
Nov 4, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Nov 4, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07212673
Lead sponsor
Yeshiva University
Responsible party
Margaret Sala (Assistant Professor, Yeshiva University) — Principal investigator
First posted
Oct 8, 2025
Start date
Nov 2, 2025
Primary completion
Oct 1, 2027 (estimated)
Completion
Oct 1, 2027 (estimated)
Last update
Nov 4, 2025

Study contacts

Margaret Sala, Ph.D.
Contact
margarita.sala@yu.edu
19723694267
Hedy Kober, Ph.D.
Contact
hedy@berkeley.edu
9174708331

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion